These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 35625618)

  • 41. The significance of virulence factors in Helicobacter pylori.
    Shiota S; Suzuki R; Yamaoka Y
    J Dig Dis; 2013 Jul; 14(7):341-9. PubMed ID: 23452293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Helicobacter pylori virulence factors in gastric carcinogenesis.
    Wen S; Moss SF
    Cancer Lett; 2009 Sep; 282(1):1-8. PubMed ID: 19111390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between histopathological status of the Helicobacter pylori infected patients and proteases of H. pylori in isolates carrying diverse virulence genotypes.
    Gharibi S; Falsafi T; Alebouyeh M; Farzi N; Vaziri F; Zali MR
    Microb Pathog; 2017 Sep; 110():100-106. PubMed ID: 28629725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic resistance and clonal relatedness of Helicobacter pylori strains isolated from stomach biopsy specimens in northeast of Iran.
    Hamidi S; Badmasti F; Sadeghpour Heravi F; Safapoor MH; Mohammad Ali Tabrizi A; Ghorbani M; Azizi O
    Helicobacter; 2020 Apr; 25(2):e12684. PubMed ID: 32074664
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets.
    Roszczenko-Jasińska P; Wojtyś MI; Jagusztyn-Krynicka EK
    Appl Microbiol Biotechnol; 2020 Dec; 104(23):9891-9905. PubMed ID: 33052519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for
    Miftahussurur M; Cruz M; Subsomwong P; Jiménez Abreu JA; Hosking C; Nagashima H; Akada J; Yamaoka Y
    Am J Trop Med Hyg; 2017 May; 96(5):1050-1059. PubMed ID: 28193745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphoma.
    Wang HP; Zhu YL; Shao W
    World J Gastroenterol; 2013 Dec; 19(45):8219-26. PubMed ID: 24363512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy.
    Sugimoto M; Yamaoka Y
    Arch Immunol Ther Exp (Warsz); 2009; 57(1):45-56. PubMed ID: 19219527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy.
    Osaki T; Mabe K; Zaman C; Yonezawa H; Okuda M; Amagai K; Fujieda S; Goto M; Shibata W; Kato M; Kamiya S
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28544222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Helicobacter pylori virulence factors in development of gastric carcinoma.
    Wang MY; Liu XF; Gao XZ
    Future Microbiol; 2015; 10(9):1505-16. PubMed ID: 26346770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helicobacter pylori and gastric cancer: factors that modulate disease risk.
    Wroblewski LE; Peek RM; Wilson KT
    Clin Microbiol Rev; 2010 Oct; 23(4):713-39. PubMed ID: 20930071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms.
    Sharndama HC; Mba IE
    Braz J Microbiol; 2022 Mar; 53(1):33-50. PubMed ID: 34988937
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Marques MS; Costa AC; Osório H; Pinto ML; Relvas S; Dinis-Ribeiro M; Carneiro F; Leite M; Figueiredo C
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33970782
    [No Abstract]   [Full Text] [Related]  

  • 54. The genetic diversity of Helicobacter pylori virulence genes is not associated with gastric atrophy progression.
    Kita M; Yokota K; Okada H; Take S; Takenaka R; Kawahara Y; Oguma K; Matsushita O; Yamamoto K
    Acta Med Okayama; 2013; 67(2):93-8. PubMed ID: 23603925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noninvasive molecular analysis of
    Ierardi E; Giorgio F; Iannone A; Losurdo G; Principi M; Barone M; Pisani A; Di Leo A
    World J Gastroenterol; 2017 Apr; 23(14):2453-2458. PubMed ID: 28465629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of Alignment-Free Phylogenetics for Rapid Genome Sequence-Based Typing of Helicobacter pylori Virulence Markers and Antibiotic Susceptibility.
    van Vliet AH; Kusters JG
    J Clin Microbiol; 2015 Sep; 53(9):2877-88. PubMed ID: 26135867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First Detection in
    Pichon M; Broutin L; Touroult-Jupin P; Cremniter J; Plouzeau C; Faure JP; Olivier R; Burucoa C
    Microb Drug Resist; 2020 Jun; 26(6):677-680. PubMed ID: 31750765
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma.
    Ferreira RM; Machado JC; Figueiredo C
    Best Pract Res Clin Gastroenterol; 2014 Dec; 28(6):1003-15. PubMed ID: 25439067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two populations of less-virulent Helicobacter pylori genotypes in Bangladesh.
    Aftab H; Miftahussurur M; Subsomwong P; Ahmed F; Khan AKA; Matsumoto T; Suzuki R; Yamaoka Y
    PLoS One; 2017; 12(8):e0182947. PubMed ID: 28797101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology and pattern of antibiotic resistance in Helicobacter pylori: scenario from Saudi Arabia.
    Rizwan M; Fatima N; Alvi A
    Saudi J Gastroenterol; 2014; 20(4):212-8. PubMed ID: 25038206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.